You are here

obesity

On a quest to challenge Novo Nordisk in obesity, transpacific startup picks up $70M — and a pair of seasoned execs

Endpoints

Tue, 10/12/21 - 11:43 pm

Sciwind Biosciences

Altimmune slips after posting 12-week data from Phase 1 trial for weight loss therapy

Seeking Alpha

Tue, 09/28/21 - 11:14 pm

clinical trials

Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub

Fierce Biotech

Wed, 09/15/21 - 10:54 am

Novo Nordisk Foundation

Broad Institute

Versanis Bio unveils $70M and a Novartis drug ready for Phase 2 test in obesity

MedCity News

Tue, 08/31/21 - 10:05 pm

clinical trials

AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics

Fierce Biotech

Tue, 07/27/21 - 10:29 am

Obesity Drug's Promise Now Hinges On Insurance Coverage

NPR

Tue, 07/6/21 - 10:39 am

Regeneron pinpoints gene variants that protect against obesity, launches search for new drugs

Fierce Biotech

Thu, 07/1/21 - 10:38 pm

Combining forces in metabolic disorders

EP Vantage

Mon, 06/28/21 - 10:45 am

clinical trials

metabolic disorders

Lumen and Novo Nordisk link up on oral biologics for cardiometabolic disease

Pharma Letter

Wed, 06/16/21 - 11:56 am

Lumen Bioscience

Novo Nordisk, armed with Wegovy green light, preps aggressive push to build obesity market

Fierce Pharma

Tue, 06/8/21 - 12:21 pm

Novo Nordisk's semaglutide set to tackle obesity with hotly-anticipated FDA green light

Fierce Pharma

Sat, 06/5/21 - 02:26 pm

Ahead of potential Ozempic approval in obesity, Novo hits 'full go mode' for launch, exec says

Fierce Pharma

Wed, 05/5/21 - 11:09 am

Novo Nordisk to launch PhIII obesity trial for oral semaglutide

Endpoints

Wed, 04/21/21 - 11:17 pm

oral semaglutide

clinical trials

Boehringer Ingelheim, Gubra to validate new Peptides for obesity

Pharmaceutical Business Review

Tue, 03/2/21 - 10:47 am

Boehringer Ingelheim

Novo Nordisk's blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight loss

Endpoints

Thu, 02/11/21 - 10:43 am

Looking to win over some skeptical analysts, Rhythm beats the drum on interim data in PhII basket study for additional indications

Endpoints

Tue, 01/26/21 - 11:19 am

Rhythm Pharmaceuticals

clinical trials

Rhythm Pharma knocked off stride as mixed PhIII obesity data for its sole big drug look ‘meh’ to many

Endpoints

Tue, 12/22/20 - 10:54 am

Rhythm Pharmaceuticals

clinical trials

FDA gives Rhythm the green light for setmelanotide, a drug aimed at reducing obesity in certain genetic disorders

Endpoints

Mon, 11/30/20 - 10:38 am

Rhythm Pharmaceuticals

Novo adds weight to its obesity goals

EP Vantage

Thu, 09/10/20 - 10:17 am

Highlights: 2020 Cardiometabolic Health Congress West Live Online

CP WIre

Fri, 08/21/20 - 12:10 pm

cardiometabolic health

cardiovascular disease

Pages